Island Pharmaceuticals Ltd (AU:ILA) has released an update.
Island Pharmaceuticals Limited reported a significant increase in revenues, surging by 11344.1% to $1,266,289 for the fiscal year ended June 30, 2024, but still posted a loss after tax of $2,864,318, which is a slight increase of 1.2% from the previous year. The company’s net tangible assets per share fell to 1.20 cents from 2.20 cents, and no dividends were paid, recommended, or declared during the period. Despite the losses, the company’s financial statements received an unmodified audit opinion.
For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.
